Velit Biopharma, founded in 2018 and headquartered in Milan, specializes in the development and registration of “hard-to-make” medicines. Through strategic partnerships with pharmaceutical companies and distributors worldwide, Velit ensures these medicines reach patients globally. With over 100 active partnership agreements spanning Europe, Asia, and the Middle East, Velit boasts a diverse portfolio of more than 50 pharmaceutical products. The company’s strong pipeline includes ongoing developments in gastroenterology, dermatology, and women’s health.

Kelso Pharma, established in 2020 and based in Edinburgh (Scotland), is dedicated to introducing innovative and value-added specialty medicines to the European healthcare markets. Supported by Apposite Capital, a leading London-based private equity firm specializing in healthcare SME businesses, Kelso Pharma is positioned for impact and growth.

Cross Border